Clinical Trial Update: The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-infected Pregnant Women. [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 pharmacokinetic study of a new tablet formulation of saquinavir in HIV-infected pregnant women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Saquinavir (saquinavir)

Snippet

Sponsor: Radboud University Medical Center | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED